Screening and Care for Fear of Cancer Recurrence in Patients With Cancer at Institut Curie
Fear of Cancer Recurrence: Prevalence, Lived Experience and Satisfaction of Supportive Care Needs in the Hospital Care Pathway. A Mixed Method Study.
Institut Curie
200 participants
Sep 8, 2025
OBSERVATIONAL
Conditions
Summary
The goals of this study is to establish the prevalence of severe forms of FCR in the oncology hospital setting, which will require a specific psychotherapeutic response. Two cancer sites are targeted: breast and pulmonary cancers. Secondary objectives include: 1) Determining threshold scores for the FCRI's 9-item severity scale for each type of cancer; 3) To identify a simple item from the FCRI for early detection of FCR in everyday clinical practice, especially using a digital format.
Eligibility
Inclusion Criteria5
- Aged 18 or over
- Clinical or pathological diagnosis of primary or recurrence of a localized/loco-regional or metastatic breast cancer, or a stage 1 or 2, or stage 3 or 4 lung cancer; or a breast or lung cancer metastatic progression
- Three months after completing treatment or three months after the start of a first treatment line for metastatic progression
- Able to comply with the scheduled assessment and interviews
- Able to read and understand the questionnaires' language (i.e. French)
Exclusion Criteria3
- Participating in another patient-reported outcome study interfering with the present study
- Any social, medical or psychological condition hindering questionnaire completion
- Being deprived of personal liberty or under guardianship
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT07357311